Data sources

Source-labeled psilocybin and psilocin literature for search, monitoring, export, and citation workflows.

How the research index is built

Eight research sources feed Psilocybin-Research.com PubMed, OpenAlex, Crossref, Europe PMC, ClinicalTrials.gov, PsyArXiv, bioRxiv, and medRxiv provide records that are reconciled into the central research index. psilocybin-research.com PubMed OpenAlex Crossref Europe PMC ClinicalTrials.gov PsyArXiv bioRxiv medRxiv
Source records are fetched, reconciled, and labeled before appearing in the live index. The original sources remain authoritative.

Research workflow

Search, filter, export, analyze, and monitor publications with source labels, publication status, citation links, alerts, API access, and a rights-safe SQLite download. Read about the methods and limitations. Explore the dataset and reuse guide or research trends by year.

Paper citation network

Cancer at the Dinner Table: Experiences of Psilocybin-Assisted Psychotherapy for the Treatment of Cancer-Related Distress

Thomas Cody Swift, Alexander Belser, Gabrielle Agin-Liebes, Neşe Devenot, Sara Terrana, Harris L. Friedman, Jeffrey Guss, Anthony P. Bossis, Stephen Ross

Publication record · Explore literature

Public tracker catalogue and stored structured reference metadata. External references may have identifiers only. No live external citation lookup is performed.

References — this paper cites (41)

  1. Patient Experiences of Psilocybin-Assisted Psychotherapy: An Interpretative Phenomenological Analysis 2017-04-28 · Expand citations
  2. Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial. 2016-12-01 · Expand citations
  3. Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial. 2016-12-01 · Expand citations
  4. Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequences. 2016-12-01 · Expand citations
  5. Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects. 2011-12-01 · Expand citations
  6. Acute, subacute and long-term subjective effects of psilocybin in healthy humans: a pooled analysis of experimental studies. 2011-11-01 · Expand citations
  7. Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness. 2011-11-01 · Expand citations
  8. Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer. 2011-01-01 · Expand citations
  9. Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later. 2008-08-01 · Expand citations
  10. Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance. 2006-08-01 · Expand citations
  11. Acute psychological and physiological effects of psilocybin in healthy humans: a double-blind, placebo-controlled dose-effect study. 2004-03-01 · Expand citations
  12. OpenAlex W15451970
  13. OpenAlex W1607118314
  14. OpenAlex W1659048389
  15. OpenAlex W1973027306
  16. OpenAlex W1974043834
  17. OpenAlex W1978118367
  18. OpenAlex W1978737075
  19. OpenAlex W1996296427
  20. OpenAlex W2007445014
  21. OpenAlex W2033002423
  22. OpenAlex W2034293461
  23. OpenAlex W2039746812
  24. OpenAlex W2044788246
  25. OpenAlex W2053764826
  26. OpenAlex W2063166841
  27. OpenAlex W2115111325
  28. OpenAlex W2164276826
  29. OpenAlex W2188432899
  30. OpenAlex W2332087446
  31. OpenAlex W2580169180
  32. OpenAlex W2734455806
  33. OpenAlex W2912967094
  34. OpenAlex W3023887779
  35. OpenAlex W3166383367
  36. OpenAlex W359263171
  37. OpenAlex W422801020
  38. OpenAlex W4249610630
  39. OpenAlex W4285719527
  40. OpenAlex W62922542
  41. OpenAlex W77146434

Cited by — these papers cite this paper (18)

  1. Participant experiences and recommendations for psychedelic clinical trials and future treatment delivery: a qualitative study with experts by experience from the Psychedelic Participant Advocacy Network 2026-10-14 · Expand citations
  2. Psychedelic integration beyond the verbal: participatory-imaginal processing as a hypothesis-generating therapeutic framework 2026-08-12 · Expand citations
  3. Psilocybin for Fear of Cancer Recurrence 2026-08-01 · Expand citations
  4. Learnings from a hybrid communities of practice group therapy model to support psilocybin-assisted therapy for patients with a terminal diagnosis 2026-07-20 · Expand citations
  5. Trajectories of psychedelic-assisted change: An observational study of a psilocybin retreat program followed by psychotherapeutic interventions 2026-07-03 · Expand citations
  6. Study Protocol for “Exploring the safety and therapeutic potential of psilocybin in the treatment of anorexia nervosa in adolescents and young adults” 2026-06-30 · Expand citations
  7. Psychedelic Experiences and Finitude in Serious Illness: A Qualitative Synthesis 2026-03-26 · Expand citations
  8. A scoping review of mystical-type experiences and mood symptom outcomes in psychedelic therapy clinical trials: comparing life-threatening disease and depressive populations 2026-02-28 · Expand citations
  9. Qualitative Research on Psilocybin-Assisted Psychotherapy for the Treatment of Mental Disorders: A Scoping Review 2025-11-24 · Expand citations
  10. “To Have the Encounter with Our Own Finiteness in that Existential Way”: Descriptions of Existential Experience in Patients with Cancer and Major Depression Participating in Psilocybin-Assisted Group Therapy 2025-08-25 · Expand citations
  11. Mystical States & Psilocybin. From Dissociation Towards Association: A Conversational Model Discussion 2025-05-31 · Expand citations
  12. Current U.S. Approaches to Studying Psychedelic Medicines Compared to Psychedelics Use Among Indigenous Groups: What Are We Missing? 2025-03-21 · Expand citations
  13. “The mushroom was more alive and vibrant”: Patient reports of synthetic versus organic forms of psilocybin 2024-10-29 · Expand citations
  14. A pilot study of the effect of group-administered psilocybin on psychological flexibility and outcomes 2024-04-05 · Expand citations
  15. Participant Reports of Mindfulness, Posttraumatic Growth, and Social Connectedness in Psilocybin-Assisted Group Therapy: An Interpretive Phenomenological Analysis 2021-06-12 · Expand citations
  16. Psychedelic-Assisted Psychotherapy Practices and Human Caring Science: Toward a Care-Informed Model of Treatment 2021-04-23 · Expand citations
  17. Four individuals' experiences during and following a psilocybin truffle retreat in the Netherlands 2021-04-16 · Expand citations
  18. Psilocybin-assisted therapy of major depressive disorder using Acceptance and Commitment Therapy as a therapeutic frame 2019-11-05 · Expand citations